根据 Gen Consulting 公司发布的市场研究报告, the global natural killer cell therapy market is predicted to be growing at a CAGR of over 36.8% 从 2022 到 2028.

该行业报告提供了全球市场的市场预测, followed by a detailed analysis of the therapy type, indication, 和地区. The global market data on natural killer cell therapy can be segmented by therapy type: CAR-NK cell therapy (modified), NK cell engager, NK cell therapy (unmodified). Natural killer cell therapy market is further segmented by indication: acute myeloid leukemia (AML), hepatocellular carcinoma (HCC), peripheral T-cell lymphoma (PTCL), relapsed/refractory (R/R) B-cell non-Hodgkin’s lymphoma (NHL). 根据地区, the natural killer cell therapy market is segmented into: 亚太地区, 欧洲, 北美.

The global natural killer cell therapy market is highly competitive. The leading players in the natural killer cell therapy market include Acepodia Inc., Affimed N.V., Celularity Inc., Century Therapeutics Inc., Cytovac A/S, Dragonfly Therapeutics Inc., Fate Therapeutics Inc., Gamida-Cell Ltd., GC Biopharma Corp., Glycostem Therapeutics B.V., iCell Gene Therapeutics LLC, ImmunityBio Inc., Innate Pharma S.A., Nkarta Inc., 赛诺菲公司, Senti Biosciences Inc., Shoreline Biosciences Inc., Takeda Pharmaceutical Company Limited, VaxCell Biotherapeutics Co. 有限公司.

以数据为中心的报告重点关注市场趋势, 各细分市场的现状和前景. 对主要地区进行全面的市场评估, 该报告对于现有参与者来说是宝贵的资产, 新进入者和未来投资者.

为什么购买这份报告?
– Get a detailed picture of the Global Natural Killer Cell Therapy Market
– Identify segments/areas to invest in over the forecast period in the Global Natural Killer Cell Therapy Market
– 了解竞争环境, 市场的领先参与者
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.